XOMA Royalty Stock Quote XOMA - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

25.87

Bid

25.51

Ask

26.24

Volume

13,976

25.45 Day's Range 27.97

13.48 52 Week Range 30.36

Market Cap

302.795M

Previous Close

27.09

Open

27.40

Last Trade

25.56

Last Trade Time

11:11:03

Financial Volume

$ 366,955

VWAP

26.2561

Average Volume (3m)

22,407

Shares Outstanding

11,704,467

Dividend Yield

PE Ratio

-7.43

Earnings Per Share (EPS)

-3.49

Revenue

4.76M

Net Profit

-40.83M

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xoma.com

Headquarters

Wilmington, Delaware, USA

Founded

XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMA. The last closing price for XOMA Royalty was $27.09. Over the last year, XOMA Royalty shares have traded in a share price range of $ 13.48 to $ 30.36.

XOMA Royalty currently has 11,704,467 shares outstanding. The market capitalization of XOMA Royalty is $317.07 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.43.

FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-3.18	-10.9466437177	29.05	29.9	25.45	28933	28.2705738	CS
4	-3.48	-11.8568994889	29.35	29.9	25.45	22980	28.20723385	CS
12	0.78	3.10880829016	25.09	30.36	22.7	22407	27.56902068	CS
26	0.8	3.19106501795	25.07	30.36	21.27	19465	26.1864217	CS
52	10.23	65.4092071611	15.64	30.36	13.48	22999	22.07055367	CS
156	1.28	5.20536803579	24.59	32.085	13.48	29405	20.73580177	CS
260	6.92	36.5171503958	18.95	46.32	13.48	36118	24.19386303	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BNZIBanzai International Inc	$ 9.355 (122.74%)	37.92M
XHGXChange TED Inc	$ 1.29 (108.23%)	10.55M
SEELSeelos Therapeutics Inc	$ 0.3837 (101.95%)	253.92M
MSSMaison Solutions Inc	$ 1.28 (79.02%)	71.22M
WVEWave Life Sciences Ltd	$ 7.795 (45.97%)	6.21M
BIVIBioVie Inc	$ 1.2994 (-53.59%)	1.41M
GHSIGuardion Health Sciences Inc	$ 6.438 (-38.80%)	263.86k
FCUVFocus Universal Inc	$ 0.2509 (-23.97%)	1.09M
VEEAVeea Inc	$ 7.675 (-21.68%)	75.37k
XPONExpion360 Inc	$ 0.091999 (-21.37%)	25.21M
SEELSeelos Therapeutics Inc	$ 0.383 (101.58%)	253.94M
NVDANVIDIA Corporation	$ 116.0697 (-0.16%)	76.32M
MLGOMicroAlgo Inc	$ 0.2094 (5.54%)	73M
MSSMaison Solutions Inc	$ 1.28 (79.02%)	71.23M
TRNRInteractive Strength Inc	$ 0.2441 (3.30%)	70.15M